MedPath

Evaluation of the effect of probiotics on late-onset sepsis in very preterm newborns

Phase 3
Completed
Conditions
late-onset sepsis in very preterm infants.
Bacterial sepsis of newborn, unspecified
Registration Number
IRCT20171218037936N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

Preterm infants weighting 1000-1500 g and less than 32 weeks’ gestational age at birth
Enrolled within 48 hours of birth

Exclusion Criteria

Major congenital anomalies(Esophageal atresia,Omphalocele,Imperforate anus)
Major congenital heart malformations
Genetic anomalies(e.g Trisomy 21 or other trisomies)
Considered likely to die within 72 hours of birth
Death before minimal entral feeding(10-20cc/kg/day)
Parents from whom informed consent cannot be obtained
Sepsis in admission(CRP>10mg/dl in 1st day of admission)
Asphyxia (grade II, III)
Maternal chorioamnionitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ate-onset sepsis. Timepoint: Baseline(admission), weekly and when clinical sepsis suspected. Method of measurement: Measurement of C-Reactive Protein and clinical clinical evaluation.
Secondary Outcome Measures
NameTimeMethod
ecrotizing enterocolitis. Timepoint: On admission, every week, when symptoms of Necrotizing enterocolitis are diagnosed. Method of measurement: Clinical evaluation based on Bell's Criteria.;Duration of primary hospitalization. Timepoint: Time of discharge. Method of measurement: Count the number of hospitalization days.;The number of days the infant takes to complete entral feeding(120mL/kg per day). Timepoint: During the study period. Method of measurement: number of days until an infant to eat 120mL / kg per day of milk.
© Copyright 2025. All Rights Reserved by MedPath